Riik: Saksamaa
keel: inglise
Allikas: HMA (Heads of Medicines Agencies)
atipamezole hydrochloride 5 mg/ml
CP Pharma Handelsgesellschaft mbH
QV03AB90
Solution for injection
atipamezole
Cats, Dogs
2011-09-30
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Revertor 5 mg/ml Solution for Injection for Dogs and Cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution for injection contains: ACTIVE SUBSTANCE: Atipamezole hydrochloride 5.0 mg (equivalent to 4.27 mg atipamezole) EXCIPIENT(S): Methyl parahydroxybenzoate 1.0 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. A clear colourless, sterile aqueous solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and Cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Atipamezole hydrochloride is a selective 2-Antagonist and indicated for reversal of the sedative effects of medetomidine and dexmedetomidine in dogs and cats. 4.3 CONTRAINDICATIONS The product should not be used in: - Breeding animals - Animals suffering from liver- or renal diseases See also section 4.7 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS After administration of the product, the animals should be allowed to rest in a quiet place. During recovery time animals should not be left unattended. Due to different dosing recommendations caution should be taken if using the product off-label in animals other than the target species. If other sedatives than medetomidine are given it must be kept in mind that the effects of those other agents may persist after reversal of (dex)medetomidine. Atipamezole does not reverse the effect of ketamine, Lugege kogu dokumenti